표피대퇴동맥 만성 동맥경화성 폐색질환의 스텐트 치료의 단기 결과
Early Results of Stenting for Chronic Artherosclerotic Occlusive Disease of Superficial Femoral Artery
Korean J Vasc Endovasc Surg 2012; 28(4): 178-183
Published online November 30, 2012 https://doi.org/10.5758/kjves.2012.28.4.178
Copyright © The Korean Society for Vascular Surgery.
Purpose: The purpose of this study is to evaluate the results of femoral artery stenting as a treatment of femoral artery occlusive disease, and to compare the primary patency and target lesion revascularization (TLR). Methods: A retrospective review identified 38 patients who underwent femoral artery stenting from November 2008 to December 2010 in Inha University Hospital. Each lesion was classified according to the Trans-Atlantic Inter-Society Consensus II. Demographic, preoperative, intraoperative, and postoperative variables were collected. Results: Forty cases of femoral artery stenting were done for 38 patients. The indications were claudication (47.4%), rest pain (13.2%), unhealed ulcer (13.2%), and toe gangrene (26.3%). The mean age and mean body mass index (BMI) were 72.50±8.19 years, and 23.0±0.05 kg/m2. There were 57.9% diabetes mellitus, 65.8% hypertension, 44.7% ischemic heart disease, 39.5% current smoker, 71.1% hyperlipidemia, 28.9% chronic renal failure (creatinine＞1.5), 23.7% obesity (BMI＞25), and 10.5% stroke. The mean follow-up was 12.1±0.03 months. There were no in-hospital mortality and 3 complications: 1 femoral artery dissection and 2 branch perforations. Six patients died and two symptomatic stent fractures were noted during the follow-up. One years' primary patency rate and TLR rate were 81.1% and 5.5%. Conclusion: Femoral artery stenting showed good results and can be a reasonable option. TLR can be considered as a new standard to evaluate the endovascular treatment.
Femoral artery, Atherosclerosis, Angioplasty, Intervention, Stents
- Bradbury AW. Angioplasty is the first line treatment for critical limb ischemia: the case against. In: Greenhalgh RM;Charing Cross Hospital, editors. Vascular and endovascular controversies. London: WB Saunders; 2003. p. 295-307.
- Holm J, Arfvidsson B, Jivegard L, Lundgren F, Lundholm K, Schersten T, et al. Chronic lower limb ischaemia: a prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA). Eur J Vasc Surg 1991;5:517-522.
- Wilson SE, Wolf GL, Cross AP. Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis:report of a prospective randomized trial in a selected group of patients. J Vasc Surg 1989;9:1-9.
- Bradbury AW, Ruckley CV. Angioplasty for lower-limb ischaemia: time for randomised controlled trials. Lancet 1996;347:277-278.
- Jackson MJ, Wolfe JH. Are infra-inguinal angioplasty and surgery comparable? Acta Chir Belg 2001;101:6-10.
- Lipsitz EC, Ohki T, Veith FJ, Suggs WD, Wain RA, Cynamon J, et al. Does subintimal angioplasty have a role in the treatment of severe lower extremity ischemia? J Vasc Surg 2003;37:386-391.
- Hynes N, Akhtar Y, Manning B, Aremu M, Oiakhinan K, Courtney D, et al. Subintimal angioplasty as a primary modality in the management of critical limb ischemia: comparison to bypass grafting for aortoiliac and femoropopliteal occlusive disease. J Endovasc Ther 2004;11:460-471.
- Scott EC, Biuckians A, Light RE, Scibelli CD, Milner TP, Meier GH 3rd, et al. Subintimal angioplasty for the treatment of claudication and critical limb ischemia: 3-year results. J Vasc Surg 2007;46:959-964.
- Ferreira M, Lanziotti L, Monteiro M, Abuhadba G, Capotorto LF, Nolte L, et al. Superficial femoral artery recanalization with self-expanding nitinol stents: long-term follow-up results. Eur J Vasc Endovasc Surg 2007;34:702-708.
- Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-1888.
- Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115:2745-2749.
- Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;33 Suppl 1:S1-S75.
- Nicoloff AD, Taylor LM Jr, McLafferty RB, Moneta GL, Porter JM. Patient recovery after infrainguinal bypass grafting for limb salvage. J Vasc Surg 1998;27:256-263.
- Chung J, Bartelson BB, Hiatt WR, Peyton BD, McLafferty RB, Hopley CW, et al. Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia. J Vasc Surg 2006;43:1183-1190.
- Bell J, Papp L, Bradbury AW. Bypass or angioplasty for severe ischaemia of the leg: the BASIL trial. In: Greenhalgh RM, Powell JT, Mitchell AW, editos. Vascular and endovascular opportunities. London: WB Saunders; 2000. p. 485494.
- Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplastyfirst revascularization strategy. J Vasc Surg 2010;51(5 Suppl):5S-17S.
- Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366:1925-1934.
- Schmieder GC, Panneton JM. Endovascular superficial femoral artery treatment: can it be as good as bypass? Semin Vasc Surg 2008;21:186-194.